Almac Discovery, RCSI form anti-cancer stem cell R&D pact – FierceBiotech
FierceBiotech |
Almac Discovery, RCSI form anti-cancer stem cell R&D pact
FierceBiotech Almac Discovery and the Royal College of Surgeons in Ireland (RCSI) have teamed up to research the effect of ALM201 on cancer stem cells. Early preclinical data suggest ALM201 may render cancer stem cells susceptible to chemotherapy and radiotherapy … |
